A detailed history of Mirova Us LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Mirova Us LLC holds 2,931,297 shares of EW stock, worth $226 Million. This represents 2.45% of its overall portfolio holdings.

Number of Shares
2,931,297
Previous 1,876,996 56.17%
Holding current value
$226 Million
Previous $136 Million 68.52%
% of portfolio
2.45%
Previous 1.7%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 23, 2025

BUY
$67.07 - $78.22 $70.7 Million - $82.5 Million
1,054,301 Added 56.17%
2,931,297 $229 Million
Q1 2025

May 15, 2025

BUY
$67.95 - $76.19 $4.61 Million - $5.16 Million
67,774 Added 3.75%
1,876,996 $136 Million
Q4 2024

Feb 10, 2025

SELL
$64.54 - $75.92 $3.48 Million - $4.09 Million
-53,910 Reduced 2.89%
1,809,222 $134 Million
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $59.7 Million - $93.8 Million
1,000,066 Added 115.87%
1,863,132 $123 Million
Q2 2024

Jul 30, 2024

BUY
$84.3 - $94.31 $1.46 Million - $1.64 Million
17,365 Added 2.05%
863,066 $79.7 Million
Q1 2024

May 09, 2024

SELL
$72.54 - $95.56 $1.07 Million - $1.4 Million
-14,699 Reduced 1.71%
845,701 $80.8 Million
Q4 2023

Jan 30, 2024

SELL
$61.71 - $77.76 $317,806 - $400,464
-5,150 Reduced 0.59%
860,400 $65.6 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $2.33 Million - $3.14 Million
33,641 Added 4.04%
865,550 $60 Million
Q2 2023

Jul 24, 2023

BUY
$81.41 - $94.33 $1.61 Million - $1.87 Million
19,816 Added 2.44%
831,909 $78.5 Million
Q1 2023

May 02, 2023

BUY
$74.26 - $84.51 $684,008 - $778,421
9,211 Added 1.15%
812,093 $67.2 Million
Q4 2022

Feb 09, 2023

BUY
$68.3 - $87.44 $1.33 Million - $1.7 Million
19,423 Added 2.48%
802,882 $59.9 Million
Q3 2022

Nov 03, 2022

BUY
$82.37 - $107.29 $64.5 Million - $84.1 Million
783,459 New
783,459 $64.7 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $47.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Mirova Us LLC Portfolio

Follow Mirova Us LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirova Us LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mirova Us LLC with notifications on news.